• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2016 - 2020年塞尔维亚和波斯尼亚和黑塞哥维那各行政单位人口密度、妇科服务可及性与宫颈癌发病率和死亡率之间的关系

Relationship Between Population Density, Availability of Gynecological Services, and Cervical Cancer Incidence and Mortality Across Administrative Units in Serbia and Bosnia and Herzegovina During 2016-2020.

作者信息

Vuković Vladimir, Štrbac Mirjana, Ristić Mioljub, Skočibušić Siniša, Cilović-Lagarija Šeila, Aćimović Jela, Šiljak Slađana, Živković Perišić Snežana, Nikolić Nataša, Ljubičić Stefan, Pustahija Tatjana, Rajčević Smiljana, Patić Aleksandra, Dugandžija Tihomir, Mandić Aljoša, Petrović Vladimir

机构信息

Institute of Public Health of Vojvodina, 21000 Novi Sad, Serbia.

Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.

出版信息

Medicina (Kaunas). 2024 Dec 2;60(12):1987. doi: 10.3390/medicina60121987.

DOI:10.3390/medicina60121987
PMID:39768867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11727680/
Abstract

: Burden of cervical cancer in Central and Eastern Europe is higher than in other parts of Europe. We analyzed cervical cancer epidemiology in Serbia and Bosnia and Herzegovina (the Federation of Bosnia and Herzegovina and the Republic of Srpska) from January 2016 to December 2020, exploring the role of available sociodemographic factors and healthcare service parameters on incidence and mortality rates, using an ecological approach based on aggregated data. : Incidence and mortality rates are standardized using the method of direct standardization with the World-ASR-W. Administrative units are grouped by tertiles of incidence and mortality to explore sociodemographic factors and healthcare parameters across these groups. : Average age-standardized incidence rates of cervical cancer per 100,000 females were 19.28 in Serbia, 12.48 in the Federation of Bosnia and Herzegovina, and 22.44 in the Republic of Srpska. Mortality rates per 100,000 females were 6.67, 5.22, and 4.56 in Serbia, the Federation of Bosnia and Herzegovina, and the Republic of Srpska, respectively. Several parameters of sociodemographics and health service usage differed significantly across units grouped by tertiles based on incidence level, i.e., female population ≥ 15 years old ( = 0.028), population density ( = 0.046), percent of gynecologists in the primary healthcare ( = 0.041), number of gynecologists per 10,000 females ≥ 15 years ( = 0.007), and the area-to-gynecologist ratio ( = 0.010). A moderate negative correlation was found between incidence and population density (rho = -0.465, = 0.017), and a moderate positive correlation between incidence and area-to-gynecologist ratio (rho = 0.534, = 0.005). : Cervical cancer remains a leading cause of cancer among women in developing countries. Implementing tailored activities, such as educational programs, preventive services, and investments in healthcare infrastructure, particularly at the administrative units' level, can help in reducing health disparities and improving health outcomes.

摘要

中欧和东欧的宫颈癌负担高于欧洲其他地区。我们分析了2016年1月至2020年12月塞尔维亚和波斯尼亚和黑塞哥维那(波斯尼亚和黑塞哥维那联邦以及塞族共和国)的宫颈癌流行病学情况,采用基于汇总数据的生态学方法,探究可用的社会人口统计学因素和医疗服务参数对发病率和死亡率的作用。发病率和死亡率采用世界年龄标准化率(World-ASR-W)直接标准化方法进行标准化。行政单位按发病率和死亡率的三分位数分组,以探究这些组中的社会人口统计学因素和医疗参数。塞尔维亚每10万名女性的宫颈癌平均年龄标准化发病率为19.28,波斯尼亚和黑塞哥维那联邦为12.48,塞族共和国为22.44。塞尔维亚、波斯尼亚和黑塞哥维那联邦以及塞族共和国每10万名女性的死亡率分别为6.67、5.22和4.56。根据发病率水平按三分位数分组的各单位之间,社会人口统计学和卫生服务利用的几个参数存在显著差异,即15岁及以上女性人口(p = 0.028)、人口密度(p = 0.046)、初级医疗保健中妇科医生的百分比(p = 0.041)、每10000名15岁及以上女性的妇科医生数量(p = 0.007)以及面积与妇科医生比例(p = 0.010)。发病率与人口密度之间存在中度负相关(rho = -0.465,p = 0.017),发病率与面积与妇科医生比例之间存在中度正相关(rho = 0.534,p = 0.005)。宫颈癌仍然是发展中国家女性癌症的主要原因。开展针对性活动,如教育项目、预防服务以及对医疗基础设施的投资,特别是在行政单位层面,有助于减少健康差距并改善健康结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78d4/11727680/613cbce29454/medicina-60-01987-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78d4/11727680/35e87c7c458a/medicina-60-01987-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78d4/11727680/7015f22131a7/medicina-60-01987-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78d4/11727680/613cbce29454/medicina-60-01987-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78d4/11727680/35e87c7c458a/medicina-60-01987-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78d4/11727680/7015f22131a7/medicina-60-01987-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78d4/11727680/613cbce29454/medicina-60-01987-g003.jpg

相似文献

1
Relationship Between Population Density, Availability of Gynecological Services, and Cervical Cancer Incidence and Mortality Across Administrative Units in Serbia and Bosnia and Herzegovina During 2016-2020.2016 - 2020年塞尔维亚和波斯尼亚和黑塞哥维那各行政单位人口密度、妇科服务可及性与宫颈癌发病率和死亡率之间的关系
Medicina (Kaunas). 2024 Dec 2;60(12):1987. doi: 10.3390/medicina60121987.
2
Estimate of cervical cancer incidence and mortality rate in Bosnia and Herzegovina.波斯尼亚和黑塞哥维那宫颈癌发病率及死亡率估计
Coll Antropol. 2014 Sep;38(3):933-7.
3
Epidemiology of Q Fever in Southeast Europe for a 20-Year Period (2002-2021).东南欧二十年(2002-2021 年)的 Q 热流行病学。
J Epidemiol Glob Health. 2024 Sep;14(3):1305-1318. doi: 10.1007/s44197-024-00288-4. Epub 2024 Sep 4.
4
Marijuana smoking among school-aged adolescents in the Brčko District of Bosnia and Herzegovina: A cross-sectional study.波斯尼亚和黑塞哥维那布尔奇科地区学龄青少年吸食大麻情况:一项横断面研究。
Acta Med Acad. 2017 May;46(1):16-26. doi: 10.5644/ama2006-124.182.
5
The influence of face masks use, immunity boosters and visiting risky places on mental health during the COVID-19 pandemic in Serbia and Republic of Srpska (Bosnia and Herzegovina).在塞尔维亚和斯普斯卡共和国(波斯尼亚和黑塞哥维那)新冠疫情期间,佩戴口罩、使用免疫增强剂以及前往高风险场所对心理健康的影响。
J Health Popul Nutr. 2025 Mar 28;44(1):92. doi: 10.1186/s41043-025-00833-2.
6
Disparities in melanoma incidence and mortality in South-Eastern Europe: Increasing incidence and divergent mortality patterns. Is progress around the corner?东南欧黑色素瘤发病率和死亡率的差异:发病率上升与死亡率模式的分化。转机即将出现?
Eur J Cancer. 2016 Mar;55:47-55. doi: 10.1016/j.ejca.2015.11.019. Epub 2016 Jan 9.
7
HEALTH TECHNOLOGY ASSESSMENT IN CENTRAL-EASTERN AND SOUTH EUROPE COUNTRIES: BOSNIA AND HERZEGOVINA.中东欧和东南欧国家的卫生技术评估:波斯尼亚和黑塞哥维那。
Int J Technol Assess Health Care. 2017 Jan;33(3):390-395. doi: 10.1017/S0266462317000058. Epub 2017 Apr 24.
8
Academician Milivoje Sarvan: The Founder of Modern Paediatrics in Bosnia and Herzegovina.米利沃耶·萨尔万院士:波斯尼亚和黑塞哥维那现代儿科学的奠基人。
Acta Med Acad. 2024 Aug;53(2):209-232. doi: 10.5644/ama2006-124.457.
9
Distribution of EGFR SNPs -191C/A and 181946G/A in patients with lung cancer depending on smoking status in the Republic of Srpska, Bosnia and Herzegovina.波斯尼亚和黑塞哥维那斯普斯卡共和国肺癌患者中表皮生长因子受体单核苷酸多态性-191C/A和181946G/A根据吸烟状况的分布情况。
J BUON. 2018 Mar-Apr;23(2):384-390.
10
Potential health impact of strong tobacco control policies in 11 South Eastern WHO European Region countries.11 个世界卫生组织欧洲区域东南部国家实施强有力的烟草控制政策对健康的潜在影响。
Eur J Public Health. 2018 Aug 1;28(4):693-701. doi: 10.1093/eurpub/cky028.

引用本文的文献

1
Knowledge and Attitudes Regarding Human Papillomavirus Vaccination Among Future Healthcare Workers in Serbia.塞尔维亚未来医护人员对人乳头瘤病毒疫苗接种的认知与态度
Vaccines (Basel). 2024 Dec 26;13(1):11. doi: 10.3390/vaccines13010011.

本文引用的文献

1
Overview of the Implementation of the First Year of Immunization against Human Papillomavirus across Different Administrative Units in Serbia and Montenegro.塞尔维亚和黑山不同行政单位人乳头瘤病毒免疫接种第一年实施情况概述
Vaccines (Basel). 2024 Jul 19;12(7):803. doi: 10.3390/vaccines12070803.
2
Prevalence of Carcinogenic Genotypes of HPV-Infected Women in a Ten-Year Period (2014-2023) in Vojvodina, Serbia.塞尔维亚伏伊伏丁那地区 HPV 感染女性在十年间(2014-2023 年)致癌基因型的流行率。
Medicina (Kaunas). 2024 Jun 1;60(6):922. doi: 10.3390/medicina60060922.
3
Disparities Contributing to Late-Stage Diagnosis of Lung, Colorectal, Breast, and Cervical Cancers: Rural and Urban Poverty in Florida.
导致肺癌、结直肠癌、乳腺癌和宫颈癌晚期诊断的差异:佛罗里达州的农村和城市贫困问题
Cancers (Basel). 2023 Oct 31;15(21):5226. doi: 10.3390/cancers15215226.
4
Sociodemographic Disparities in the Diagnosis and Prognosis of Patients With Cervical Cancer: An Analysis of the Surveillance, Epidemiology, and End Results Program.宫颈癌患者诊断与预后的社会人口学差异:监测、流行病学和最终结果计划分析
Cureus. 2023 Jul 6;15(7):e41477. doi: 10.7759/cureus.41477. eCollection 2023 Jul.
5
The Contributions of Population Distribution, Healthcare Resourcing, and Transportation Infrastructure to Spatial Accessibility of Health Care.人口分布、医疗资源配置和交通基础设施对医疗保健空间可达性的贡献。
Inquiry. 2023 Jan-Dec;60:469580221146041. doi: 10.1177/00469580221146041.
6
Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative.2020 年全球宫颈癌发病率和死亡率估计:世卫组织全球消除宫颈癌倡议的基线分析。
Lancet Glob Health. 2023 Feb;11(2):e197-e206. doi: 10.1016/S2214-109X(22)00501-0. Epub 2022 Dec 14.
7
Barriers to cervical cancer and breast cancer screening uptake in low- and middle-income countries: a systematic review.中低收入国家宫颈癌和乳腺癌筛查接受度的障碍:系统评价。
Health Policy Plan. 2023 Apr 11;38(4):509-527. doi: 10.1093/heapol/czac104.
8
Participation rate in cervical cancer screening in general practice related to the proximity of gynecology care facilities: A 3 year follow-up cohort study.初级保健中宫颈癌筛查的参与率与妇科保健设施的接近程度有关:一项为期 3 年的随访队列研究。
Front Public Health. 2022 Oct 17;10:955559. doi: 10.3389/fpubh.2022.955559. eCollection 2022.
9
Effect of Pap-smear and sociodemographic factors on cervical cancer risk in Estonia: A population-based case-control study.巴氏涂片和社会人口因素对爱沙尼亚宫颈癌风险的影响:一项基于人群的病例对照研究。
Cancer Epidemiol. 2022 Oct;80:102231. doi: 10.1016/j.canep.2022.102231. Epub 2022 Jul 25.
10
Quantifying the Effects of Medical Examination and Possible Risk Factors against the Incidence of Cervical Cancer in a Low Human Papillomavirus Vaccination Coverage: An Ecological Study in Japan.在人乳头瘤病毒疫苗接种率较低的情况下,量化医学检查及可能的风险因素对宫颈癌发病率的影响:日本的一项生态学研究
Cancers (Basel). 2021 Sep 24;13(19):4784. doi: 10.3390/cancers13194784.